Abstract:AbstractAlzheimer’s disease (AD) is a progressive neurodegenerative disease that represents the most common form of dementia among the elderly. Despite the fact that AD was studied for decades, the underlying mechanisms that trigger this neuropathology remain unresolved. Since the onset of cognitive deficits occurs generally within the 6th decade of life, except in rare familial case, advancing age is the greatest known risk factor for AD. To unravel the pathogenesis of the disease, numerous studies use cellular and animal models based on genetic mutations found in rare early onset familial AD (FAD) cases that represent less than 1 % of AD patients. However, the underlying process that leads to FAD appears to be distinct from that which results in late-onset AD. As a genetic disorder, FAD clearly is a consequence of malfunctioning/mutated genes, while late-onset AD is more likely due to a gradual accumulation of age-related malfunction. Normal aging and AD are both marked by defects in brain metabolism and increased oxidative stress, albeit to varying degrees. Mitochondria are involved in these two phenomena by controlling cellular bioenergetics and redox homeostasis. In the present review, we compare the common features observed in both brain aging and AD, placing mitochondrial in the center of pathological events that separate normal and pathological aging. We emphasize a bioenergetic model for AD including the inverse Warburg hypothesis which postulates that AD is a consequence of mitochondrial deregulation leading to metabolic reprogramming as an initial attempt to maintain neuronal integrity. After the failure of this compensatory mechanism, bioenergetic deficits may lead to neuronal death and dementia. Thus, mitochondrial dysfunction may represent the missing link between aging and sporadic AD, and represent attractive targets against neurodegeneration.

Impact of mitochondrial fission and fusion on neuronal health and incidence of dementia

Deregulation of Mitochondrial Fusion and Fission in Neurodegenerative Diseases

The systems biology of mitochondrial fission and fusion and implications for disease and aging

Impairing the Mitochondrial Fission and Fusion Balance: A New Mechanism of Neurodegeneration

Mitochondrial Network State Scales mtDNA Genetic Dynamics

Chronic mitochondrial fragmentation elicits a neuroprotective Warburg-like effect in Drosophila neurons

Mfn2 Ablation Causes an Oxidative Stress Response and Eventual Neuronal Death in the Hippocampus and Cortex.

Mitochondrial Dynamics and Proteins Related to Neurodegenerative Diseases

Altered Brain Energetics Causes Mitochondrial Fission Arrest in Alzheimer’s Disease

The Role of Abnormal Mitochondrial Dynamics in the Pathogenesis of Alzheimer's Disease.

Significantly reduced, but balanced, rates of mitochondrial fission and fusion are sufficient to maintain the integrity of yeast mitochondrial DNA

Mitochondria in Alzheimer's Disease Pathogenesis

Mitochondrial DNA Damage as a Mechanism of Cell Loss in Alzheimer's Disease

Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer’s disease

[The Role of Mitochondrial Dynamics in Neurodegeneration].

P2‐349: Altered Brain Energetics Induces Mitochondrial Fission Arrest in Alzheimer's Disease

Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases

Chronic Progressive External Ophthalmoplegia Coexistent with Motor Neuron Disease in A Patient with A Novel Large-Scale Mitochondrial Dna Deletion

Age-Related Phasic Patterns of Mitochondrial Maintenance in Adult Caenorhabditis elegans Neurons.

Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer's Disease Pathogenesis

Mitostasis in age-associated neurodegeneration